Technology

The Bone Printing Solution

Ossiform® is founded on a worldwide IP protected technology developed in 2015.

Our solution is a bio-ink composed of powder particles suspended in a solid but meltable fatty acid matrix. The bio-ink enables a new 3D additive manufacturing process where objects are constructed directly from a computer-aided design (CAD) file.

The bio-ink is loaded into a syringe, heated to its melting point and extruded as a thin line onto a cooler stage on which it re-solidifies. The fatty acid is then removed through burning and the powders are sintered together.

Preclinical Proof

Preclinical evidence suggests the Ossiform Bone performs according to design objectives. The bone substitutes:

  • demonstrate mechanical robustness and are free from contaminants,
  • support the rapid formation of new vascularized bone,
  • integrate with neighboring bone in vivo, and
  • show clear signs of bone substitute resorption and no signs of infection in preclinical studies.

These results have been published in peer-reviewed scientific papers (See Publications section below).

Ossiform clean room operator

Ossiform’s aim is to allow surgeons to reconstruct bone without the risks of permanent foreign body implantation or the inherent variability of allografts.

We work in close collaboration with physicians to develop bone substitutes that are optimized for the specific demands of diversified clinical applications and integrate seamlessly into existing workflows.

3D printed bioceramic

​Publications

Thygesen, T., et al. Comparison of off-the-shelf β-tricalcium phosphate implants with novel resorbable 3D printed implants in mandible ramus of pigs. Bone (2022): 116370.
Get access here

​Jensen MB, et al. Treating mouse skull defects with 3D printed fatty acid and tricalcium phosphate implants. Journal of Tissue Engineering and Regenerative Medicine. (2020): 1-11
Get access here

​Jensen MB, et al. Composites of fatty acids and ceramic powders are versatile biomaterials for personalized implants and controlled release of pharmaceuticals. Bioprinting 10 (2018): e00027
Get access here

​Slots C, et al. Simple additive manufacturing of an osteoconductive ceramic using suspension melt extrusion. Dental Materials 33.2 (2017): 198-208.
Get access her

​Jensen MB et al. The performance of a new generation of 3D printed and drug and stem cell loaded implants in vitro and in vivo. DASCS2017 Stem Cell Conference. 2017.
See poster

Sascha Senck, et al. Ceramic additive manufacturing and microstructural analysis of tricalcium phosphate implants using X-ray microcomputed tomography. Open Ceramics (2024): 100628.
Get access here